CPT 0822T: Clinical Staff Monitoring During Psychedelic Medication Therapy

CPT code 0822T designates hourly, in‑person monitoring and intervention by clinical staff under the direction of a physician or other qualified healthcare professional during a patient’s psychedelic medication therapy. The code captures concurrent staff support that addresses potential emotional and physiological issues arising during sessions and ensures patient safety. Nationally, this code is relevant as psychedelic-assisted treatments expand in clinical practice and payers consider coverage frameworks for associated staffing and supervision needs. Key payers in the landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what the code represents clinically and operationally, which payers are commonly considered in benchmarking and coverage discussions, and what to expect in terms of coding context and service setting. The publication provides benchmarks where available, summarizes recent policy considerations affecting coverage of psychedelic therapy support services, and outlines clinical context for accurate coding and billing of concurrent staff monitoring reported per hour. Data not available in the input is noted where applicable.

Billing Code Overview

CPT code 0822T describes a service in which clinical staff, under the direction of a physician or other qualified healthcare professional (QHP), provide continuous, in‑person monitoring and intervention during a patient's psychedelic medication therapy. This service is furnished concurrently with a first physician or other QHP and is reported per hour.

Service Type

Clinical monitoring and intervention during psychedelic medication therapy (concurrent staff service)

Typical Site of Service

Behavioral health or specialty treatment setting where psychedelic-assisted therapy is provided, including inpatient or outpatient psychiatric units and designated therapy clinics.

Clinical Context

A 35-year-old patient with treatment-resistant major depressive disorder arrives for a scheduled psychedelic-assisted medication therapy session. The session is conducted in a licensed outpatient behavioral health clinic where a lead physician or other qualified healthcare professional (QHP) administers the psychedelic medication and remains responsible for overall clinical direction. Clinical staff (e.g., psychiatric nurse, behavioral health technician) provide continuous, in‑person monitoring and intervention during the medication experience while the physician/QHP remains physically present and supervising another part of the care team. The monitoring period lasts multiple hours to observe for and manage potential intense emotional responses, blood pressure or heart rate changes, or emergent distress requiring de‑escalation or brief medical interventions.

Typical workflow:

Patient check-in, pre-session safety assessment, medication administration and brief stabilization by the physician/QHP.
Continuous in‑room monitoring by clinical staff who document mental status, vital signs, and behavioral observations hourly and intervene as needed (comfort measures, grounding techniques, assistance with orientation, coordination of emergent medical care if physiological instability occurs).
Physician/QHP remains present concurrently managing medication effects and directing staff interventions; staff time providing continuous, in‑person monitoring is reported using 0822T per hour.
Post‑session debrief and focused assessment by the physician/QHP and staff, with documentation of duration of monitoring, interventions performed, and patient disposition (discharge to home with caregiver or transfer for further observation).

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when monitoring required substantially greater intensity or time than typical for the hour reported.
`23`	Unusual anesthesia	Use if general anesthesia or deep sedation unrelated to the procedure is required for the monitoring period (rare).
`52`	Reduced services	Use when monitoring is partially performed or abbreviated compared with typical service duration.
`53`	Discontinued procedure	Use if monitoring is started but discontinued due to patient instability or other immediate termination.
`54`	Surgical care only	Not typically used; include only if responsibility is split and clinic documents portion of care unrelated to monitoring.
`55`	Postoperative management only	Use when the reporting clinician provided only post‑procedure monitoring separate from the primary session.
`56`	Preoperative management only	Use when only pre‑session monitoring was provided by this clinician.
`62`	Two surgeons	Use if two qualified clinicians share responsibility for concurrent direct care during the session and payor allows split billing.
`QK`	Medical direction of two or more concurrent anesthesia providers	Use if billing rules require anesthesia supervisory modifiers for sedation provided concurrently.
`QX`	CRNA service with medical direction	Use if a certified registered nurse anesthetist provides sedation services under medical direction and separate billing rules apply.

Taxonomy Code	Specialty	Notes
`2084P0800X`	Psychiatry & Neurology - Psychiatry	Psychiatrists often serve as the physician/QHP directing psychedelic medication therapy.
`2084P0802X`	Psychiatry & Neurology - Child & Adolescent Psychiatry	Child/adolescent psychiatrists when treating younger adults under appropriate protocols.
`186N00000X`	Nursing - Registered Nurse	Registered nurses commonly provide continuous in‑person monitoring and interventions.
`367500000X`	Behavioral Health & Social Service Providers - Behavioral Health Technician	Allied clinical staff who perform direct observation and patient support during sessions.
`208D00000X`	Anesthesiology	Anesthesiologists or nurse anesthetists may be involved when deeper sedation or airway management is anticipated.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F33.2`	Major depressive disorder, recurrent severe without psychotic features	Common indication for psychedelic-assisted medication therapy requiring continuous staff monitoring for emotional and physiological responses.
`F32.2`	Major depressive disorder, single episode severe without psychotic features	Single severe depressive episodes are treated in some protocols requiring monitored medication sessions.
`F41.1`	Generalized anxiety disorder	Anxiety disorders may be treated adjunctively with psychedelic-assisted therapy; monitoring addresses acute anxiety responses.
`F43.1`	Post-traumatic stress disorder	PTSD is an emerging indication for psychedelic-assisted therapy; continuous in‑person monitoring addresses trauma‑related emotional activation.
`F34.1`	Dysthymia (persistent depressive disorder)	Chronic mood disorders considered for therapy where prolonged monitoring may be needed during dosing sessions.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`0922T`	Preparation, psychiatric treatment protocol, including psychometric testing and therapy planning specific to psychedelic-assisted therapy	Pre‑session assessment and planning that precedes monitored medication sessions.
`0923T`	Administration of psychedelic medication (first hour) including medication dosing and supervision	The primary medication administration session during which `0822T` monitoring may occur concurrently.
`90834`	Psychotherapy, 45 minutes with patient when performed separately	Individual psychotherapy provided before or after the monitored medication session as part of overall treatment.
`99024`	Postoperative follow-up visit global period, related to procedure performed	Post‑session follow‑up visits for clinical status checks and documentation of recovery when used by payors.
`A0425`	Ground ambulance service, advanced life support, non‑emergency transport, level 2	Used when emergent transport is needed during or immediately after a monitored session due to physiological instability.

OpenPayer

Summary & Overview